Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
73 hedge funds and large institutions have $71.7M invested in Histogen Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 8 closing their positions.
81% more call options, than puts
Call options by funds: $583K | Put options by funds: $322K
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
31% more capital invested
Capital invested by funds: $54.9M → $71.7M (+$16.8M)
4% more funds holding
Funds holding: 70 → 73 (+3)
23% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 26
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$2.01M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$606K |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$500K |
| 5 |
JP Morgan Chase
New York
|
+$378K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.23M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.3M |
| 3 |
Morgan Stanley
New York
|
-$749K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$714K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$654K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Balyasny Asset Management
Chicago,
Illinois
| – | -$137K | -149 | Closed |
|
|
SO
77
STRS Ohio
Columbus,
Ohio
| – | -$123K | -134 | Closed |
|
|
DIA
78
Denver Investment Advisors
Denver,
Colorado
| – | -$50K | -54 | Closed |
|
79
Parallax Volatility Advisers
San Francisco,
California
| – | -$18K | -20 | Closed |
|
|
AG
80
Advisor Group
Phoenix,
Arizona
| – | -$5K | -5 | Closed |
|
|
RA
81
Royce & Associates
New York
| – | -$4K | -5 | Closed |
|
HSTO Hedge Fund Activity: Q1 2018 in Review
73 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2018, worth a combined $71.7M — up 31% from $54.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new HSTO positions and 8 closed out — a net gain of 3 holders — while 20 added to existing stakes and 26 trimmed.
The largest buyer was BlackRock, adding an estimated $4M. The largest seller was AQR Capital Management, cutting an estimated $2.23M.
- 73 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2018, up from 70 in Q4 2017.
- Funds reported $71.7M of Histogen Inc. Common Stock stock for Q1 2018, up 31% quarter-over-quarter.
- 11 funds opened new Histogen Inc. Common Stock positions in Q1 2018 and 8 closed out, a net change of +3 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2018 was BlackRock, an estimated $4M added.
- The largest Histogen Inc. Common Stock seller in Q1 2018 was AQR Capital Management, an estimated $2.23M sold.
Based on aggregated 13F filings for Q1 2018.